Bill Amendment: IL SB1412 | 2023-2024 | 103rd General Assembly

NOTE: For additional amemendments please see the Bill Drafting List

---

Bill Title: DHFS-GENERIC DRUG LABEL

Status: 2023-03-31 - Senate Committee Amendment No. 1 Rule 3-9(a) / Re-referred to Assignments [SB1412 Detail]

Download: Illinois-2023-SB1412-Senate_Amendment_001.html

---

Sen. Laura M. Murphy

Filed: 3/1/2023

10300SB1412sam001 LRB103 26068 KTG 57981 a
AMENDMENT TO SENATE BILL 1412
AMENDMENT NO. ______. Amend Senate Bill 1412 on page 1, by
replacing lines 7 through 9 with the following:
"(20 ILCS 2205/2205-40 new)
Sec. 2205-40. Generic prescription drug contracting.
(a) As used in this Section:
"Eligible prescription drug" means a prescription drug
approved under 21 U.S.C. Sec. 355(c) that is not under patent.
"Generic drug" means a drug that is approved in accordance
with an application referencing an eligible prescription drug
that is submitted under subsection (j) of Section 505 of the
federal Food, Drug, and Cosmetic Act (21 U.S.C. Sec. 355(j)).
(b) The Department of Healthcare and Family Services shall
implement"; and
on page 3, by replacing line 5 with the following:
"(g) As used in this Section:

10300SB1412sam001 - 2 - LRB103 26068 KTG 57981 a
"Eligible prescription drug" means a prescription drug
approved under 21 U.S.C. Sec. 355(c) that is not under patent.
"Generic drug" means a drug that is approved in accordance
with an application referencing an eligible prescription drug
that is submitted under subsection (j) of Section 505 of the
federal Food, Drug, and Cosmetic Act (21 U.S.C. Sec. 355(j)).
(h) This Section is repealed on January 1, 2025.".